FAP and cancer: FAPα, also known as seprase, has long been known to be expressed in the cancer associated fibroblasts of tumor stroma, and plays multiple roles in neoangiogenesis, invasion, and metastasis [10–12]; FAPα has been investigated as an invasion biomarker in various cancers, and has also been explored as a target for cancer therapy [13–14].